2161 - 2170 of 6255 Results
Title
Year
- Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized Trial2025OPENTitle: Allogeneic Bone Marrow‐Derived Mesenchymal Stem Cells for Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70028Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.70028Citation Count: 0
-
OPENTitle: Preferences regarding Disclosure of Risk for Parkinson's Disease in a Population‐based StudyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 12Issue #: 2Start Page: 203End Page: 209Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mdc3.14264Best OA location URL: https://doi.org/10.1002/mdc3.14264Citation Count: 0
-
OPENTitle: Structure of the second phosphoubiquitin–binding site in parkinJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 7Start Page: 102114End Page: 102114Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102114Best OA location URL: http://www.jbc.org/article/S0021925822005555/pdfCitation Count: 21
- Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers2020OPENTitle: Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 77Issue #:Start Page: 57End Page: 63Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.05.033Best OA location URL: http://www.prd-journal.com/article/S1353802020301504/pdfCitation Count: 23
-
OPENTitle: Dopamine D1–D5 Receptors in Brain Nuclei: Implications for Health and DiseaseJournal Name: ReceptorsPublisher: MDPI AGVol: 3Issue #: 2Start Page: 155End Page: 181Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/receptors3020009Best OA location URL: https://www.mdpi.com/2813-2564/3/2/9/pdf?version=1712907165Citation Count: 26
-
OPENTitle: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neuronsJournal Name: CellPublisher: Elsevier BVVol: 187Issue #: 14Start Page: 3671End Page: 3689.e23Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030Best OA location URL: https://doi.org/10.1016/j.cell.2024.05.030Citation Count: 19
-
OPENTitle: Stress and mindfulness in Parkinson’s disease – a survey in 5000 patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00152-9Best OA location URL: https://www.nature.com/articles/s41531-020-00152-9.pdfCitation Count: 61
-
OPENTitle: Use of Figurative Language by People With Parkinson Disease to Describe “Off” PeriodsJournal Name: Neurology Clinical PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 11Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/cpj.0000000000001059Best OA location URL: https://cp.neurology.org/content/neurclinpract/11/4/e462.full.pdfCitation Count: 4
- The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease2017OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 87
- O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect2020OPENTitle: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effectJournal Name: Physical BiologyPublisher: IOP PublishingVol: 18Issue #: 1Start Page: 016002End Page: 016002Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1478-3975/abb6dcBest OA location URL: https://iopscience.iop.org/article/10.1088/1478-3975/abb6dc/pdfCitation Count: 18